FDA Inspection 829253 — Hikma Pharmaceuticals USA, Inc.
The FDA completed an inspection of Hikma Pharmaceuticals USA, Inc. on Jun 7, 2013 in Eatontown, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jun 7, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Eatontown, NJ (United States)